MedPath

Nevirapine

These highlights do not include all the information needed to use Nevirapine safely and effectively. See full prescribing information for Nevirapine. Nevirapine Tablets, USP 200 mg for oral use Initial U.S. Approval: 1996

Approved
Approval ID

4f065674-4719-4c79-ba0d-549040d77f17

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 20, 2012

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nevirapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65162-209
Application NumberANDA078195
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nevirapine
Product Specifications
Route of AdministrationORAL
Effective DateAugust 20, 2012
FDA Product Classification

INGREDIENTS (8)

NEVIRAPINEActive
Quantity: 200 mg in 1 1
Code: 99DK7FVK1H
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nevirapine - FDA Drug Approval Details